Close Menu

NEW YORK – Quest Diagnostics said on Tuesday that it is acquiring its joint venture partner interests in Indiana-based Mid America Clinical Laboratories (MACL) and will operate the business by itself.

The largest independent clinical lab in Indiana, MACL was formed two decades ago as a joint venture between Quest, the Ascension St. Vincent hospital system, and Community Health Network. With the acquisition, Secaucus, New Jersey-based Quest will take full ownership of MACL's Indianapolis-based lab and around 50 patient service centers across Indiana.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.